Expression and DNA methylation patterns of Tslc1 and Dal-1 genes in hepatocellular carcinomas induced by N-nitrosodiethylamine in rats

被引:22
作者
Tsujiuchi, Toshifumi [1 ]
Sugata, Eriko
Masaoka, Tomomi
Onishi, Mariko
Fujii, Hiromasa
Shimizu, Kyoko
Honoki, Kanya
机构
[1] Kinki Univ, Fac Engn Sci, Dept Life Sci, Lab Canc Biol & Bioinformat, Osaka 5778502, Japan
[2] Nara Med Univ, Dept Orthoped Surg, Nara 6348521, Japan
关键词
D O I
10.1111/j.1349-7006.2007.00480.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To assess the involvement of the TSLC cascade in hepatocarcinogenesis, we investigated the expression and DNA methylation patterns of the genes Tslc1 and Dal-1 in hepatocellular carcinomas (HCC) induced using N-nitrosodiethylamine (DEN) in rats. Six-week-old male F344 rats received a single intraperitoneal injection of DEN at a dose of 10 mg/kg body weight, followed by combined treatment with partial hepatectomy and colchicine to induce cell-cycle disturbance and a selection procedure consisting of 2-acetylaminofluorene and carbon tetrachloride. Total RNA was extracted from 10 HCC, and the expression levels of Tslc1 and Dal-1 were measured using semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis. Three of 10 HCC showed reduced expression of Tslc1, compared with normal liver tissues, but no changes in the expression level of Dal-1 were found. For DNA methylation analysis, bisulfite sequencing was performed. The 5' upstream region of Tslc1 was methylated in the three HCC in which its expression was reduced, but was unmethylated in normal liver tissue. Western blot analysis also revealed reduced expression of Tslc1 protein in the three HCC. These results suggest that alterations to the TSLC cascade might have a role in hepatocarcinogenesis using DEN in rats.
引用
收藏
页码:943 / 948
页数:6
相关论文
共 40 条
[1]   INITIATION OF CHEMICAL CARCINOGENESIS REQUIRES CELL-PROLIFERATION [J].
CAYAMA, E ;
TSUDA, H ;
SARMA, DSR ;
FARBER, E .
NATURE, 1978, 275 (5675) :60-62
[2]   Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells [J].
Charboneau, AL ;
Singh, V ;
Yu, TX ;
Newsham, IF .
INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (02) :181-188
[3]   Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines [J].
Fukami, T ;
Fukuhara, H ;
Kuramochi, M ;
Maruyama, T ;
Isogai, K ;
Sakamoto, M ;
Takamoto, S ;
Murakami, Y .
INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (01) :53-59
[4]   Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer [J].
Fukuhara, H ;
Kuramochi, M ;
Fukami, T ;
Kasahara, K ;
Furuhata, N ;
Nobukuni, T ;
Maruyama, T ;
Isogai, K ;
Sekiya, T ;
Shuin, T ;
Kitamura, T ;
Reeves, RH ;
Murakami, Y .
JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (06) :605-609
[5]   Actomyosin-dependent microtubule rearrangement in lysophosphatidic acid-induced neurite remodeling of young cortical neurons [J].
Fukushima, Nobuyuki ;
Morita, Yuka .
BRAIN RESEARCH, 2006, 1094 :65-75
[6]   A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2 [J].
Gomyo, H ;
Arai, Y ;
Tanigami, A ;
Murakami, Y ;
Hattori, M ;
Hosoda, F ;
Arai, K ;
Aikawa, Y ;
Tsuda, H ;
Hirohashi, S ;
Asakawa, S ;
Shimizu, N ;
Soeda, E ;
Sakaki, Y ;
Ohki, M .
GENOMICS, 1999, 62 (02) :139-146
[7]   Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas [J].
Heller, G ;
Fong, KM ;
Girard, L ;
Seidl, S ;
End-Pfützenreuter, A ;
Lang, G ;
Gazdar, AF ;
Minna, JD ;
Zielinski, CC ;
Zöchbauer-Müller, S .
ONCOGENE, 2006, 25 (06) :959-968
[8]  
Higgins GM, 1931, ARCH PATHOL, V12, P186
[9]   Cell adhesion system and human cancer morphogenesis [J].
Hirohashi, S ;
Kanai, Y .
CANCER SCIENCE, 2003, 94 (07) :575-581
[10]   Aberrant methylation of the 5′ CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanINs [J].
Jansen, M ;
Fukushima, N ;
Rosty, C ;
Walter, K ;
Altink, R ;
van Heek, T ;
Hruban, R ;
Offerhaus, JG ;
Goggins, M .
CANCER BIOLOGY & THERAPY, 2002, 1 (03) :293-296